Back to All Articles
You must be logged in to create a new articleBrowse articles with tag: Drug
All Articles
Intra-Cellular Therapies Surges 15% Following Settlement of Caplyta ANDA Litigation with Sandoz
Shares of Intra-Cellular Therapies (NASDAQ: ITCI) increased by nearly 15% last week after the company reached a significant settlement with... Read More
Patexia Insight 213: The Revlimid Dispute From Antitrust Battles to Patent Litigation
Revlimid (lenalidomide), developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma... Read More
Moderna Scores a Victory in the Covid-19 Vaccine Patent Dispute with Pfizer and BioNTech
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and BioNTech. The... Read More
Top 10 Pharmaceuticals Losing Exclusivity in the US in 2024
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent... Read More
BeiGene Files Patent Infringement Lawsuits Under Hatch-Waxman Act Against Sandoz and MSN Pharmaceuticals
BeiGene, a biotechnology company, has taken legal action by filing patent infringement lawsuits against pharmaceutical companies Sandoz and MSN Pharmaceuticals,... Read More
Expect Future FDA Clarification on Machine Learning-Enabled Medical Devices
Written by: Paige L. Cappelli The inaugural AAMI/FDA neXus medical device standards conference was held February 20-23, 2024 in Washington DC.... Read More